ESTA
ESTABLISHMENT LABS HOLDINGS INC.
NASDAQ · Healthcare · Medical - Devices · CR
$65.78
+3.10%Year over year
Reported trailing growth
- Revenue
- +38.6%
- EBITDA
- +83.1%
- EBIT
- +70.2%
- EPS
- +57.1%
- Free cash flow
- +46.4%
- Operating cash flow
- +55.0%
Forward estimates
Based on analyst estimates
- Revenue
- +28.8%
- EBITDA
- +444.7%
- EPS
- +72.5%
Three-year CAGR
- Revenue
- +9.3%
- EBITDA
- +60.4%
- EBIT
- +22.0%
- Net income
- +39.6%
- EPS
- +42.7%
- Free cash flow
- +22.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026